Literature DB >> 23130611

Circulating fatty acid binding protein as a marker of intestinal failure in septic patients.

Marcel Cerqueira César Machado, Hermes Vieira Barbeiro, Fabiano Pinheiro da Silva, Heraldo Possolo de Souza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23130611      PMCID： PMC3672560          DOI： 10.1186/cc11653

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  5 in total

1.  Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study.

Authors:  Iris C Vermeulen Windsant; Femke A Hellenthal; Joep P M Derikx; Martin H Prins; Wim A Buurman; Michael J Jacobs; Geert Willem H Schurink
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

2.  The intestinal fatty acid binding protein diagnosing gut dysfunction in acute pancreatitis: a pilot study.

Authors:  Liya Pan; Xinying Wang; Weiqin Li; Ning Li; Jieshou Li
Journal:  Pancreas       Date:  2010-07       Impact factor: 3.327

Review 3.  Fatty acid-binding proteins as plasma markers of tissue injury.

Authors:  Maurice M A L Pelsers; Wim T Hermens; Jan F C Glatz
Journal:  Clin Chim Acta       Date:  2005-02       Impact factor: 3.786

Review 4.  Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?

Authors:  Gaël Piton; Cyril Manzon; Benoit Cypriani; Franck Carbonnel; Gilles Capellier
Journal:  Intensive Care Med       Date:  2011-03-12       Impact factor: 17.440

5.  Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia.

Authors:  Simon A W G Dello; Kostan W Reisinger; Ronald M van Dam; Marc H A Bemelmans; Toin H van Kuppevelt; Maartje A J van den Broek; Steven W M Olde Damink; Martijn Poeze; Wim A Buurman; Cornelis H C Dejong
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240
  5 in total
  6 in total

1.  I-FABP as biomarker for the early diagnosis of acute mesenteric ischemia and resultant lung injury.

Authors:  Rachel G Khadaroo; Spyridon Fortis; Saad Y Salim; Catherine Streutker; Thomas A Churchill; Haibo Zhang
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

2.  Prediction of Gut Wall Integrity Loss in Viral Gastroenteritis by Non-Invasive Marker.

Authors:  Hala G Elnady; Lobna S Sherif; Maysa T Saleh; Inas R El-Alameey; Mai M Youssef; Amal I El Shafie; Iman Helwa; Haiam Abdel Raouf; Ahmed N El-Taweel
Journal:  Open Access Maced J Med Sci       Date:  2015-03-05

3.  Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury.

Authors:  Hermes Vieira Barbeiro; Marcel Autran César Machado; Heraldo Possolo de Souza; Fabiano Pinheiro da Silva; Marcel Cerqueira César Machado
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

4.  Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease.

Authors:  Stepan Coufal; Alena Kokesova; Helena Tlaskalova-Hogenova; Jiri Snajdauf; Michal Rygl; Miloslav Kverka
Journal:  J Immunol Res       Date:  2016-03-24       Impact factor: 4.818

5.  Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease.

Authors:  Stepan Coufal; Alena Kokesova; Helena Tlaskalova-Hogenova; Barbora Frybova; Jiri Snajdauf; Michal Rygl; Miloslav Kverka
Journal:  J Immunol Res       Date:  2020-03-03       Impact factor: 4.818

6.  Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients.

Authors:  Ginga Suzuki; Ryo Ichibayashi; Saki Yamamoto; Hibiki Serizawa; Yoshimi Nakamichi; Masayuki Watanabe; Mitsuru Honda
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.